Skip to main navigation Skip to search Skip to main content

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Valbenazine as Adjunctive Treatment in Subjects with Schizophrenia

Project: Research

Project Details

StatusFinished
Effective start/end date12/5/22 → 05/29/25

Funding

  • Neurocrine Biosciences Incorporated: $30,063.00